Sirona Biochem, TFChem S.a.r.l. preclinical data

In mice, Sirona's sodium-glucose cotransporter type 2 (SGLT2) inhibitor dose-dependently reduced blood glucose levels by up to 50% compared to untreated controls. Sirona licensed the SGLT2 inhibitor f...